About this trial
Trigger finger is a common disease of the hand involving swelling and inflammation of the tendon which flexes a finger, causing catching, locking, and/or pain. Trigger finger is typically treated by hand surgeons with a steroid injection through the front/palm side of the hand into the area near the tendon (i.e., at the base of the affected finger). This steroid injection is often combined with a local anesthetic (numbing agent) to help reduce short-term pain from the injection. However, the front/palm side of the hand is known to be very sensitive, and the steroid injection can be quite painful as the needle pierces the front/palm skin.
To reduce the pain of steroid injections for trigger finger, a different approach involves performing the injection from the back/dorsal side of the hand, which is thought to be less sensitive (and therefore less painful) than the front/palm side of the hand. This technique is sometimes used and has been previously studied, but it is not clear if it can offer less injection-related pain than standard treatment.
Accordingly, this study will be comparing short-term injection-associated pain between front/palm side and back/dorsal side steroid injections for trigger finger. The study will also seek to understand what area of the hand is numbed by the anesthetic when doing a front/palm side injection versus a back/dorsal side injection of the hand. Overall, the investigators hypothesize that back/dorsal side injections will be less painful than front/palm side injections for trigger fingers and that the area of numbing from the anesthetic will be equivalent between both types of injections.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Be 18 years of age or older
Have a diagnosis of trigger finger (can be any of the 5 digits)
Opting to receive a CSI for their triggering finger
Disqualifiers
Decline to obtain a CSI for trigger finger management
Receiving multiple CSI for trigger finger management at the appointment
Past CSI and/or surgery to the digit involved
Unable to communicate in English
Trial design
Parallel
Treatments tested in this trial
Dorsal webspace combined corticosteroid and anesthetic injection
Procedure/SurgeryThe dorsal webspace injection consists of a 1cc mixture of 0.5cc triamcinolone (Kenalog) 10mg/mL and 0.5cc 1% lidocaine for analgesic purposes.
Palmar combined corticosteroid and anesthetic injection
Procedure/SurgeryThe palmar injection consists of a 1cc mixture of 0.5cc triamcinolone (Kenalog) 10mg/mL and 0.5cc 1% lidocaine for analgesic purposes.
Treatment groups
Trial outcomes
Primary outcomes
Visual Analogue Scale (VAS) - Pain
100mm mechanical rating scale for pain, ranging from 0mm ("no pain") to 100mm ("pain as bad as it could be"); higher scores indicate a worse outcome.
Numerical Rating Scale (NRS) - Pain
11-point numerical rating scale for pain, ranging from 0 (no pain) to 10 (worst pain ever possible); higher scores indicate a worse outcome.
Short-Form McGill Pain Questionnaire (SFMPQ) - Present Pain Intensity (PPI)
5-point combined numerical-word rating scale for pain, ranging from 1 (mild) to 5 (excruciating); higher scores indicate a worse outcome.
Secondary outcomes
Sensory Assessment - Light Touch
Semmes-Weinstein 2.0g monofilament test as threshold of sensory impairment
Sensory Assessment - Pain
Pinprick pain sensation with an 18-gauge sharp needle tip
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kevin Zuo
Lead sponsor
University Health Network, Toronto
Sponsor institution